5HT2A Receptors are Involved in the Pharmaco-Toxicological Effects of the Synthetic Cannabinoids JWH-018 and 5F-PB22: in Vivo Studies in Mice
Introduction: Since their first appearance on the illicit drugs market, Synthetic Cannabinoids (SCs) have been frequently detected in biological samples from patients involved in several intoxication and death cases. To date, their serious adverse effects have been primarily related to their action...
Saved in:
| Main Authors: | G. Corli, M. Tirri, T. Bernardi, F. Boccuto, M. Borsari, M. Bassi, S. Bilel, M. Marti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Emerging Trends in Drugs, Addictions, and Health |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667118223000326 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurobiological Sequelae of the Passive or Voluntary Administration of the Synthetic Cannabinoid Receptor Agonist JWH-018
by: M.A. De Luca
Published: (2024-12-01) -
In Vivo Pharmaco-Toxicological Characterization of Brorphine and its Possible Emerging Analogues Orphine, Fluorphine, Chlorphine and Iodorphine
by: S. Bilel, et al.
Published: (2024-12-01) -
From JWH-018 to OXIZIDS: Structural Changes in Newly Emerged Synthetic Cannabinoids in the European Union from December 2008 to December 2021
by: R. Andrews, et al.
Published: (2024-12-01) -
Pharmaco-toxicological aspects of thymol in veterinary medicine. A systematic review
by: Denisa Pérez Gaudio, et al.
Published: (2025-08-01) -
Pharmaco-Technological Characterization, Structural Analysis, and Toxicological Evaluation of the Novel Polyene Antibiotic Roseofungin for Drug Development
by: Amankeldy Sadanov, et al.
Published: (2025-03-01)